Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc.
1:19-cv-01489
📡 5G SEP • ETSI DeclaredOverview
Parties
Plaintiff
Merck Sharp & Dohme Corp. Operating Company
Represented By
17 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Williams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Williams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Schrader, Byrd & Companion, PLLC - Wheeling
The Maxwell Centre, Suite 500, 32 - 20th Street
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Williams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Williams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Schrader Companion Duff & Law, PLLC
401 Main Street, Wheeling, WV 26003
Schrader, Byrd & Companion, PLLC - Wheeling
The Maxwell Centre, Suite 500, 32 - 20th Street
Williams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Williams & Connolly LLP - Washington
725 Twelfth St, NW, Washington, DC 20005
Counter Claimant
Mylan Pharmaceuticals Inc. Operating Company
Represented By
9 Attorneys ListedMorris James LLP
500 Delaware Avenue, Suite 1500
Steptoe & Johnson PLLC - Bridgeport
400 White Oaks Blvd, Bridgeport, WV 26330
Katten Muchin Rosenman LLP - NC
550 S. Tyron Street, Suite 2900
Katten Muchin Rosenman LLP
575 Madison Avenue, New York, NY 10022
Katten Muchin Rosenman LLP - NC
550 S. Tyron Street, Suite 2900
Steptoe & Johnson PLLC - Bridgeport
400 White Oaks Blvd, Bridgeport, WV 26330
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,326,708 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 48,216,103 P | US Continuation / Sibling | View Official Patent → |
Sun Pharmaceutical Industries Ltd. et al. v. Merck Sharp & Dohme Corp. et al.
Dr. Reddy's Laboratories, Inc. et al. v. Merck Sharp & Dohme Corp. et al.
Teva Pharmaceuticals USA, Inc. v. Merck Sharp & Dohme Corp.
Mylan Pharmaceuticals, Inc. v. Merck Sharp & Dohme Corp. et al.
Merck Sharp & Dohme Corp. v. Sandoz Inc.
Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc.
Merck Sharp & Dohme Corp. v. Sun Pharmaceutical Industries Ltd.
Merck Sharp & Dohme Corp. v. Alvogen Pine Brook LLC
Merck Sharp & Dohme Corp. v. Watson Laboratories, Inc.
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP • ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7326708
Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor
|
Filed: 2004-06-23
Issued: 2008-02-05
|
Expiring Soon (4 days)
+884d PTA
Expires: 2026-11-24
|
|
|
US8414921
Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin
|
Filed: 2006-12-12
Issued: 2013-04-09
|
Active (1.7 yrs remaining)
+587d PTA
Expires: 2028-07-21
|
Patent Enforceability & Injunction Risk Assessment
Narrowing Window — Less than 6 months of enforceable term remains. Courts rarely grant preliminary or permanent injunctions when term expiration is imminent.
High PTA (+884 days) / Cellect Scrutiny — Over 884 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
49
Dispositive
8
Granted
17
Denied
1
Pending / Review
24
Motions by Category
Key Dispositive Motions & Rulings